Attached files

file filename
8-K - FORM 8-K - PATTERSON COMPANIES, INC.d305973d8k.htm

Exhibit 99.1

Patterson Companies Reports Improved Third Quarter Operating Results

St. Paul, MN—February 23, 2012— Patterson Companies, Inc. (Nasdaq: PDCO) today reported that consolidated sales totaled $895,030,000 in the third quarter of fiscal 2012 ended January 28, an increase of 9% from $824,650,000 in the year-earlier period. Net income of $53,108,000 or $0.50 per diluted share included incremental expense of $0.03 per diluted share related to Patterson’s Employee Stock Ownership Plan (ESOP). Excluding this ESOP-related expense, third quarter earnings were $0.53 per diluted share. Patterson reported earnings of $55,396,000 or $0.47 per diluted share in the third quarter of fiscal 2011. As reported previously, the ESOP expense will affect fiscal 2012 earnings by an estimated $0.12 per diluted share.

Sales of Patterson Dental, Patterson’s largest business, increased 9% from the year-earlier period to $605,041,000 in this year’s third quarter.

 

   

Sales of consumable dental supplies and printed office products increased over 3% in the third quarter.

 

   

Sales of dental equipment and software increased more than 21% from the year-earlier level, driven by double-digit increases in sales of CEREC dental restorative products and digital radiography products.

 

   

Sales of other services and products, consisting primarily of technical service, parts and labor, software support services and artificial teeth, were down 4% from last year’s third quarter.

Third quarter sales of the Webster Veterinary unit increased nearly 17% to $174,643,000, with the August 2011 acquisition of American Veterinary Supply Corporation, a full-service veterinary distributor located on Long Island, accounting for 3% of the unit’s sales growth for this period. Sales of Patterson Medical, the rehabilitation supply and equipment unit, declined 2% to $115,346,000, primarily reflecting weak equipment sales during the quarter.

Scott P. Anderson, president and chief executive officer, commented: “We are pleased with Patterson’s third quarter results, indicating that we are performing effectively amid unsettled economic conditions. Within Patterson Dental, we posted solidly higher sales of consumable supplies as patient levels continued to strengthen during this period. Sales of dental equipment, paced by CEREC systems and digital radiography products, rebounded from the unexpectedly weak performance in last year’s third quarter. Our equipment business benefited from marketing efforts aimed at capitalizing upon the growing acceptance of new digital technologies, which are enabling dentists to strengthen their productivity, generate additional income and improve clinical outcomes. We believe ample opportunities exist for our new-technology offerings, and we will continue to focus our marketing initiatives on further boosting demand for capital equipment.”

He continued: “Webster’s strong third quarter sales growth was attained during the unit’s seasonally softest period of the year. Sales of consumable supplies, which constitute the largest component of Webster’s revenue stream, increased 15% during the quarter, while equipment sales rose 35%. Despite the challenging economy, pet owners are continuing to increase expenditures on veterinary care. Through its relatively new equipment and service business, which has strengthened Webster’s full-service platform, our companion-pet veterinary unit is increasingly well-positioned to capitalize upon positive pet ownership and spending trends. We intend to continue investing in this component of Webster’s business.”

Anderson added: “Patterson Medical’s third quarter performance, which was consistent with our internal forecasts, was affected by changes, including the impact of new regulations, affecting the nation’s health care system. We believe these unfolding developments have dampened demand for rehabilitation products and equipment during fiscal 2012. Although this situation is likely to persist until market uncertainties are clarified, we believe Patterson Medical is positioned to take maximum advantage of global demographic trends fueling the growth of the rehabilitation market.”


Patterson repurchased approximately 3.2 million common shares during the third quarter under its 25 million share buyback authorization that expires in 2016. Approximately 12.3 million shares remain available for repurchase under this authorization. The additional interest expense associated with Patterson’s previously reported third quarter long-term debt issuance reduced earnings for this period by approximately $0.01 per share.

Patterson narrowed its financial guidance for fiscal 2012 to $1.90 to $1.94 per diluted share from the previously issued $1.90 to $1.97.

ESOP Expense Reconciliation Table

Dollars in thousands, except EPS

 

     Three Months Ended      Nine Months Ended  
     January 28,
2012
     January 29,
2011
     January 28,
2012
     January 29,
2011
 

Net Income

   $ 53,108       $ 55,396       $ 150,672       $ 162,678   

Incremental ESOP Expense

     3,468         —           10,372         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted Net Income (non-GAAP)

   $ 56,576       $ 55,396       $ 161,044       $ 162,678   
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted Earnings Per Share

   $ 0.50       $ 0.47       $ 1.34       $ 1.36   

Incremental ESOP expense

     0.03            0.10      
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted Earnings Per Share (non-GAAP)

   $ 0.53       $ 0.47       $ 1.44       $ 1.36   
  

 

 

    

 

 

    

 

 

    

 

 

 

About Patterson Companies, Inc.

Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets.

Dental Market

As Patterson’s largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.

Veterinary Market

Webster Veterinary is the nation’s second largest distributor of consumable veterinary supplies, equipment and software, diagnostic products, vaccines and pharmaceuticals to companion-pet veterinary clinics.

Rehabilitation Market

Patterson Medical is the world’s leading distributor of rehabilitation supplies and non-wheelchair assistive patient products to the physical and occupational therapy markets. The unit’s global customer base includes hospitals, long-term care facilities, clinics and dealers.

# # #

This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond the Company’s ability to control. The Company cautions shareholders and prospective investors that the following factors, among others, may cause actual results to differ materially from those indicated by the forward-looking statements: competition within the dental, veterinary, and rehabilitative and assistive living supply industries; changes in the economics of dentistry, including reduced growth in expenditures by private dental insurance plans, the effects of economic conditions and the effects of healthcare reform, which may affect future per capita expenditures for dental services and the ability and willingness of dentists to invest in high-technology products; the effects of healthcare related


legislation and regulation which may affect expenditures or reimbursements for rehabilitative and assistive products; changes in the economics of the veterinary supply market, including reduced growth in per capita expenditures for veterinary services and reduced growth in the number of households owning pets; the ability of the Company to maintain satisfactory relationships with its sales force; unexpected loss of key senior management personnel; unforeseen operating risks; risks associated with the dependence on manufacturers of the Company’s products; and the ability of the Company to successfully integrate the recent acquisitions into its existing business. Forward-looking statements are qualified in their entirety by the cautionary language set forth in the Company’s filings with the Securities and Exchange Commission.

 

For additional information contact:

  

R. Stephen Armstrong

   Richard G. Cinquina

Executive Vice President & CFO

   Equity Market Partners

651/686-1600

   904/415-1415

Third Quarter Conference Call and Replay

Patterson’s third quarter earnings conference call will start at 10:00 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. The conference call will be archived on Patterson’s web site. A replay of the third quarter conference call can be heard for one month at 1-303-590-3030 and providing the conference ID: 4509188.


PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except for per share amounts)

(Unaudited)

 

     Three Months Ended     Nine Months Ended  
     January 28,     January 29,     January 28,     January 29,  
     2012     2011     2012     2011  

Net sales

   $ 895,030      $ 824,650      $ 2,599,327      $ 2,531,851   

Gross profit

     289,534        280,875        848,793        840,276   

Operating expenses

     199,628        188,168        593,635        568,393   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     89,906        92,707        255,158        271,883   

Other expense, net

     (8,043     (6,423     (19,393     (14,478
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before taxes

     81,863        86,284        235,765        257,405   

Income taxes

     28,755        30,888        85,093        94,727   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 53,108      $ 55,396      $ 150,672      $ 162,678   
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings per share:

        

Basic

   $ 0.50      $ 0.47      $ 1.35      $ 1.37   

Diluted

   $ 0.50      $ 0.47      $ 1.34      $ 1.36   

Shares:

        

Basic

     106,504        117,994        111,539        118,544   

Diluted

     107,206        118,837        112,226        119,331   

Dividends declared per common share

   $ 0.12      $ 0.10      $ 0.36      $ 0.30   

Gross margin

     32.3     34.1     32.7     33.2

Operating expenses as a % of net sales

     22.3     22.8     22.8     22.4

Operating income as a % of net sales

     10.0     11.2     9.8     10.7

Effective tax rate

     35.1     35.8     36.1     36.8

 

-more-


PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

 

     January 28,      April 30,  
     2012      2011  
     (Unaudited)         

ASSETS

     

Current assets:

     

Cash and short-term investments

   $ 538,092       $ 388,665   

Receivables, net

     428,587         465,170   

Inventory

     334,775         336,094   

Prepaid expenses and other current assets

     39,048         40,780   
  

 

 

    

 

 

 

Total current assets

     1,340,502         1,230,709   

Property and equipment, net

     196,598         189,583   

Goodwill and other intangible assets

     1,018,654         1,022,832   

Investments and other

     110,071         121,844   
  

 

 

    

 

 

 

Total Assets

   $ 2,665,825       $ 2,564,968   
  

 

 

    

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

     

Current liabilities:

     

Accounts payable

   $ 189,407       $ 210,033   

Other accrued liabilities

     171,538         157,398   

Current maturities of long-term debt

     —           —     
  

 

 

    

 

 

 

Total current liabilities

     360,945         367,431   

Long-term debt

     850,000         525,000   

Other non-current liabilities

     103,793         111,997   
  

 

 

    

 

 

 

Total liabilities

     1,314,738         1,004,428   

Stockholders’ equity

     1,351,087         1,560,540   
  

 

 

    

 

 

 

Total Liabilities and Stockholders' Equity

   $ 2,665,825       $ 2,564,968   
  

 

 

    

 

 

 

 

-more-


PATTERSON COMPANIES, INC.

SUPPLEMENTARY FINANCIAL DATA

(Dollars in thousands)

(Unaudited)

 

     Three Months Ended     Nine Months Ended  
     January 28,     January 29,     January 28,     January 29,  
     2012     2011     2012     2011  

Consolidated Net Sales

        

Consumable and printed products

   $ 550,888      $ 520,011      $ 1,695,822      $ 1,653,946   

Equipment and software

     273,573        232,594        687,249        668,372   

Other

     70,569        72,045        216,256        209,533   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   $ 895,030      $ 824,650      $ 2,599,327      $ 2,531,851   
  

 

 

   

 

 

   

 

 

   

 

 

 

Dental Supply

        

Consumable and printed products

   $ 311,356      $ 301,688      $ 932,461      $ 932,688   

Equipment and software

     231,372        190,567        567,312        545,123   

Other

     62,313        64,793        189,240        185,125   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   $ 605,041      $ 557,048      $ 1,689,013      $ 1,662,936   
  

 

 

   

 

 

   

 

 

   

 

 

 

Rehabilitation Supply

        

Consumable and printed products

   $ 80,510      $ 80,170      $ 272,235      $ 261,360   

Equipment and software

     28,783        32,103        91,542        98,731   

Other

     6,053        5,603        19,591        17,885   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   $ 115,346      $ 117,876      $ 383,368      $ 377,976   
  

 

 

   

 

 

   

 

 

   

 

 

 

Veterinary Supply

        

Consumable and printed products

   $ 159,022      $ 138,153      $ 491,126      $ 459,898   

Equipment and software

     13,418        9,924        28,395        24,518   

Other

     2,203        1,649        7,425        6,523   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   $ 174,643      $ 149,726      $ 526,946      $ 490,939   
  

 

 

   

 

 

   

 

 

   

 

 

 

Other (Expense) Income, net

        

Interest income

   $ 1,052      $ 1,577      $ 3,778      $ 7,118   

Interest expense

     (8,358     (6,380     (20,880     (19,499

Other

     (737     (1,620     (2,291     (2,097
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ (8,043   $ (6,423   $ (19,393   $ (14,478
  

 

 

   

 

 

   

 

 

   

 

 

 

 

-more-


PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

     Nine Months Ended  
     January 28,     January 29,  
     2012     2011  

Operating activities:

    

Net income

   $ 150,671      $ 162,678   

Depreciation & amortization

     30,432        30,835   

Stock-based compensation

     9,428        7,911   

ESOP compensation

     544        1,575   

Change in assets and liabilities, net of acquired

     37,587        (11,544
  

 

 

   

 

 

 

Net cash provided by operating activities

     228,662        191,455   

Investing activities:

    

Additions to property and equipment, net of disposals

     (25,051     (29,199

Acquisitions and equity investments

     (14,193     (52,343
  

 

 

   

 

 

 

Net cash used in investing activities

     (39,244     (81,542

Financing activities:

    

Dividends paid

     (39,800     (35,543

Share repurchases

     (323,519     (36,947

Proceeds from issuance of long-term debt

     325,000        —     

Other financing activities

     7,935        11,574   
  

 

 

   

 

 

 

Net cash used in financing activities

     (30,384     (60,916

Effect of exchange rate changes on cash

     (9,607     (1,549
  

 

 

   

 

 

 

Net increase in cash and cash equivalents

   $ 149,427      $ 47,448